Results 31 to 40 of about 6,942 (191)

Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria

Frontiers in Medicine, 2022
Malaria is still an endemic disease in Africa, with many imported cases in Europe. The standard treatment is intravenous artesunate for severe malaria and oral artemisinin-based combination therapy (ACT) for uncomplicated malaria.
Marion Louvois, Loïc Simon, Loïc Simon, Christelle Pomares, Christelle Pomares, Pierre-Yves Jeandel, Elisa Demonchy, Michel Carles, Michel Carles, Pascal Delaunay, Pascal Delaunay, Johan Courjon, Johan Courjon   +12 more
doaj   +1 more source

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies [PDF]

, 2013
Background: This study aimed to synthesize available evidence on the efficacy of dihydroartemisinin-piperaquine (DHP) in treating uncomplicated Plasmodium vivax malaria in people living in endemic countries.
Cho Naing (492196), Vanessa Racloz (321919), Marcel Tanner (33894), Maxine Anne Whittaker (492197), Joon Wah Mak, Aung Kyan, Marcel Tanner, Naing, Cho, Maxine Anne Whittaker, Cho Naing, Naing Cho, Racloz, Vanessa, Racloz Vanessa, Whittaker, Maxine Anne, Vanessa Racloz, Joon Wah Mak (207190), Kyan Aung, Tanner, Marcel, Mak, Joon Wah, Mak Joon Wah, Simon Andrew Reid, Simon Andrew Reid (492199), Reid, Simon Andrew, Tanner Marcel, Reid Simon Andrew, Aung, Kyan, Whittaker Maxine Anne, Kyan Aung (492198)   +27 more
core   +1 more source

Role of Anopheles stephensi Mosquitoes in Malaria Outbreak, Djibouti, 2019

Emerging Infectious Diseases, 2021
Anopheles stephensi mosquitoes share urban breeding sites with Aedes aegypti and Culex quinquefasciatus mosquitoes in the Republic of Djibouti. We present evidence that A.
Vincent Pommier de Santi, Bouh Abdi Khaireh, Thomas Chiniard, Bruno Pradines, Nicolas Taudon, Sébastien Larréché, Abdoulraouf Bourhan Mohamed, Franck de Laval, Franck Berger, Florian Gala, Madjid Mokrane, Nicolas Benoit, Lionel Malan, Abdoulilah Ahmed Abdi, Sébastien Briolant   +14 more
doaj   +1 more source

Detection of Falsified Antimalarial Sulfadoxine-Pyrimethamine and Dihydroartemisinin-Piperaquine Drugs Using a Low-Cost Handheld Near-Infrared Spectrometer

Journal of Analytical Methods in Chemistry, 2022
Falsified drugs are of serious concern to public health worldwide, particularly for developing countries where quality control of drugs is inefficient.
Moussa Yabré, Abdoul Karim Sakira, Moumouni Bandé, Bertrand W. F. Goumbri, Sandrine M. Ouattara, Souleymane Fofana, Touridomon Issa Somé   +6 more
doaj   +1 more source

Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children

Nature Communications, 2021
Intermittent preventive treatment with dihydroartemisinin-piperaquine (DP) is protective in children against malaria. Here, the authors analyze plasma drug concentration, malaria incidence, and drug resistance markers from a clinical trial in Uganda and ...
Erika Wallender, Ali Mohamed Ali, Emma Hughes, Abel Kakuru, Prasanna Jagannathan, Mary Kakuru Muhindo, Bishop Opira, Meghan Whalen, Liusheng Huang, Marvin Duvalsaint, Jenny Legac, Moses R. Kamya, Grant Dorsey, Francesca Aweeka, Philip J. Rosenthal, Rada M. Savic   +15 more
doaj   +1 more source

Prediction of Improved Antimalarial Chemoprevention with Weekly Dosing of Dihydroartemisinin-Piperaquine [PDF]

Antimicrobial Agents and Chemotherapy, 2017
ABSTRACT Intermittent preventive treatment (IPT) is used to reduce malaria morbidity and mortality, especially in vulnerable groups such as children and pregnant women. IPT with the fixed dose combination of piperaquine (PQ) and dihydroartemisinin (DHA) is being evaluated as a potential mass treatment to control and eliminate artemisinin ...
Jesmin Permala, Joel Tärning, François Nosten, Nicholas J. White, Mats O. Karlsson, Martin Bergstrand   +5 more
openaire   +4 more sources

Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study. [PDF]

Lancet Infect Dis, 2023
Background: Tafenoquine, co-administered with chloroquine, is approved for the radical cure (prevention of relapse) of Plasmodium vivax malaria. In areas of chloroquine resistance, artemisinin-based combination therapies are used to treat malaria.
Sutanto I, Soebandrio A, Ekawati LL, Chand K, Noviyanti R, Satyagraha AW, Subekti D, Santy YW, Crenna-Darusallam C, Instiaty I, Budiman W, Prasetya CB, Lardo S, Elyazar I, Duparc S, Cedar E, Rolfe K, Fernando D, Berni A, Jones S, Kleim JP, Fletcher K, Sharma H, Martin A, Taylor M, Goyal N, Green JA, Tan LK, Baird JK.   +28 more
europepmc   +2 more sources

Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria [PDF]

Cochrane Database of Systematic Reviews, 2014
The World Health Organization (WHO) recommends Artemisinin-based Combination Therapy (ACT) for treating uncomplicated Plasmodium falciparum malaria. This review aims to assist the decision-making of malaria control programmes by providing an overview of the relative effects of dihydroartemisinin-piperaquine (DHA-P) versus other recommended ACTs.To ...
Zani, Babalwa, Gathu, Michael, Donegan, Sarah, Olliaro, Piero L, Sinclair, David   +4 more
openaire   +2 more sources

Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. [PDF]

, 2015
BACKGROUND: The World Health Organization recommends artemisinin-based combination (ACT) for the treatment of uncomplicated malaria. Post-licensure safety data on newly registered ACT is critical for evaluating their risk/benefit profile in malaria ...
Abdulla, Salim, Halidou, Tinto, Ogutu, Bernhards, Mulokozi, Abdunoor, Yawson, Abena, Adjuik, Martin, Baiden, Rita, Owusu-Agyei, Seth, Akparibo, Raymond, Valea, Innocent, Gyapong, Margaret, Macete, Eusebio, Sevene, Esperanca, Smith, Peter, Binka, Fred, Adjei, Alex, Osei, Isaac, Compaoré, Guillaume, Upunda, Gabriel Leonard, Oduro, Abraham, Sie, Ali   +20 more
core   +1 more source

Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy [PDF]

Evidence Based Medicine, 2016
Commentary on : Kakuru A, Jagannathan P, Muhindo MK, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 2016;374:928–39.[OpenUrl][1][CrossRef][2][PubMed][3] Malaria in pregnancy has devastating consequences for mother and fetus.
Hill, Jenny, ter Kuile, Feiko O
openaire   +4 more sources